Entity Public Float of Eloxx Pharmaceuticals, Inc. from 31 Dec 2011 to 30 Jun 2025

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
Eloxx Pharmaceuticals, Inc. quarterly Entity Public Float in USD history and change rate from 31 Dec 2011 to 30 Jun 2025.
  • Eloxx Pharmaceuticals, Inc. Entity Public Float for the quarter ending 30 Jun 2025 was $330,000.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

Eloxx Pharmaceuticals, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $330,000 30 Jun 2025 10-K 17 Mar 2026 2025 FY
Q2 2022 $16,650,960 -$120,753,438 -88% 30 Jun 2022 10-K 31 Mar 2023 2022 FY
Q2 2021 $137,404,398 +$54,571,776 +66% 30 Jun 2021 10-K 30 Mar 2022 2021 FY
Q2 2020 $82,832,622 -$186,137,549 -69% 30 Jun 2020 10-K 12 Mar 2021 2020 FY
Q2 2019 $268,970,171 +$21,438,323 +8.7% 28 Jun 2019 10-K 06 Mar 2020 2019 FY
Q2 2018 $247,531,848 +$240,439,148 +3390% 30 Jun 2018 10-K 14 Mar 2019 2018 FY
Q2 2017 $7,092,700 30 Jun 2017 10-K 16 Mar 2018 2017 FY
Q4 2016 $2,520,758 -$4,286,497 -63% 31 Dec 2016 10-K 13 Oct 2017 2017 FY
Q4 2015 $6,807,255 -$2,295,378 -25% 31 Dec 2015 10-K 13 Oct 2016 2016 FY
Q4 2014 $9,102,633 -$19,557,981 -68% 31 Dec 2014 10-K 09 Oct 2015 2015 FY
Q4 2013 $28,660,614 +$12,937,588 +82% 31 Dec 2013 10-K 29 Sep 2014 2014 FY
Q4 2012 $15,723,026 -$2,090,489 -12% 31 Dec 2012 10-K 11 Sep 2013 2013 FY
Q4 2011 $17,813,515 31 Dec 2011 10-K/A 26 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.